Double strike approach for tumor attack: Engineering T cells using CD40L:CD28 chimeric co-stimulatory proteins for enhanced tumor targeting in adoptive cell therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: München, Ludwig-Maximilians-Universität, Dissertation, 2021

Keyword: Signaltransduktion
T-Lymphozyt
Immuntherapie
B-Lymphozyt

Event: Veröffentlichung

(where): München

(who): Universitätsbibliothek der Ludwig-Maximilians-Universität

(when): 2021

Creator: Olguín Contreras, Luis Felipe

Contributor: Nößner, Elfriede

DOI: 10.5282/edoc.28916

URN: urn:nbn:de:bvb:19-289165

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Olguín Contreras, Luis Felipe
Nößner, Elfriede
Universitätsbibliothek der Ludwig-Maximilians-Universität

Time of origin

2021

Other Objects (12)

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy

Hochschulschrift

Chimäre Antigen-Rezeptoren mit kombinierter CD28-CD3ζ-OX40-Signaldomaine [CD28-CD3ζ-OX40-Signaldomaine] für die adoptive T-Zell-Therapie von Tumoren

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells

Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma

Identification, isolation and characterization of T cell receptors for adoptive T cell therapy in tumor and viral infections

Tumor Hypoxia and Circulating Tumor Cells

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models

Hochschulschrift

Modulating T-cell activation with tunable stimulatory nanoarrays

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy

Hochschulschrift

Chimäre Antigen-Rezeptoren mit kombinierter CD28-CD3ζ-OX40-Signaldomaine [CD28-CD3ζ-OX40-Signaldomaine] für die adoptive T-Zell-Therapie von Tumoren

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells

Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma

Identification, isolation and characterization of T cell receptors for adoptive T cell therapy in tumor and viral infections

Tumor Hypoxia and Circulating Tumor Cells

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models

Hochschulschrift

Modulating T-cell activation with tunable stimulatory nanoarrays

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy

Hochschulschrift

Chimäre Antigen-Rezeptoren mit kombinierter CD28-CD3ζ-OX40-Signaldomaine [CD28-CD3ζ-OX40-Signaldomaine] für die adoptive T-Zell-Therapie von Tumoren

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells

Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma

Identification, isolation and characterization of T cell receptors for adoptive T cell therapy in tumor and viral infections

Tumor Hypoxia and Circulating Tumor Cells

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models

Hochschulschrift

Modulating T-cell activation with tunable stimulatory nanoarrays

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Double strike approach for tumor attack: Engineering T cells using CD40L:CD28 chimeric co-stimulatory proteins for enhanced tumor targeting in adoptive cell therapy

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy

Chimäre Antigen-Rezeptoren mit kombinierter CD28-CD3ζ-OX40-Signaldomaine [CD28-CD3ζ-OX40-Signaldomaine] für die adoptive T-Zell-Therapie von Tumoren

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells

Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma

Identification, isolation and characterization of T cell receptors for adoptive T cell therapy in tumor and viral infections

Tumor Hypoxia and Circulating Tumor Cells

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models

Modulating T-cell activation with tunable stimulatory nanoarrays

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy

Chimäre Antigen-Rezeptoren mit kombinierter CD28-CD3ζ-OX40-Signaldomaine [CD28-CD3ζ-OX40-Signaldomaine] für die adoptive T-Zell-Therapie von Tumoren

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells

Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma

Identification, isolation and characterization of T cell receptors for adoptive T cell therapy in tumor and viral infections

Tumor Hypoxia and Circulating Tumor Cells

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models

Modulating T-cell activation with tunable stimulatory nanoarrays

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy

Chimäre Antigen-Rezeptoren mit kombinierter CD28-CD3ζ-OX40-Signaldomaine [CD28-CD3ζ-OX40-Signaldomaine] für die adoptive T-Zell-Therapie von Tumoren

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells

Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma

Identification, isolation and characterization of T cell receptors for adoptive T cell therapy in tumor and viral infections

Tumor Hypoxia and Circulating Tumor Cells

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models

Modulating T-cell activation with tunable stimulatory nanoarrays

Related objects

Reset password